Access
To read this story in full you will need to login or make a payment (see right).
News
Nature Medicine 5, 474 (1999)
doi:10.1038/8347
Smallpox stocks: new focus for research?
Alan Dove1
- New York
The US Institute of Medicine (IOM) has released a report asserting that stocks of live variola virus, the causative agent of smallpox, could be used to develop improved smallpox vaccines and antiviral agents. The report dovetails with a new initiative by the Department of Health and Human Services (HHS) to beef up the nation's defenses against bioterrorism, but stands at odds with the current World Health Organization (WHO) plan to destroy existing stocks of variola.
To read this story in full you will need to login or make a payment (see right).
